Exemption number (b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents.The investigation was unable to determine a cause for the reported difficulty.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
It was reported that the procedure was performed to treat a target lesion in the right superficial femoral artery.The armada 35 dilatation catheter was advanced over a non-abbott guide wire.Resistance was noted during advancement, and the armada 35 was never able to enter the sheath or anatomy.The decision was made to remove the armada 35 dilatation catheter.Some resistance was noted during removal; however, the guide wire remained in the anatomy.A second same size armada 35 was advanced over the same guide wire and no resistance was noted.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|